Ultragenyx: Progress Is Real, But Profitability Is The Real Test (Rating Upgrade)

Ultragenyx Pharmaceutical gains accelerated FDA approval for GENGLYCOS (GSDIa) at a $2.7M list, but launch may be slow. Read ...